Full Text View
Tabular View
No Study Results Posted
Related Studies
Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer (FLAG)
This study has been completed.
Study NCT00275951   Information provided by National Taiwan University Hospital

First Received on January 11, 2006.   Last Updated on November 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastric Cancer
Additional conditions recognized in this trial
Stomach Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Site
Stomach Diseases
Interventions listed in this trial
Cetuximab Plus P-HDFL
Additional drug interventions recognized in this trial
Cetuximab
Cisplatin
Leucovorin
More general drug interventions related to this trial
Antineoplastic Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Taiwan University Hospital
Taipei Veterans General Hospital,Taiwan
National Health Research Institutes, Taiwan
Chang Gung Memorial Hospital
Tri-Service General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services